Vir Biotechnology (VIR) Notes Payables (2019)
Vir Biotechnology (VIR) posted Notes Payables of $12.4 million for Q4 2019.
Vir Biotechnology (VIR) Notes Payables (2019) Analysis & Trends
Vir Biotechnology has reported Notes Payables for 1 years, with the latest figure at $12.4 million in Q4 2019.
- Quarterly Notes Payables changed N/A year-over-year to $12.4 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $12.4 million (changed N/A YoY) and the FY2019 annual result came in at $12.4 million, changed N/A from the prior year.
- Notes Payables was little changed at $12.4 million in Q4 2019 per VIR's latest filing.
- Over five years, Notes Payables peaked at $12.4 million in Q4 2019 and troughed at $12.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 12.45 Mn |